Clinical application of the AMOY 9-in-1 panel to lung cancer patients-Reference-Cited by-同舟云学术

Clinical application of the AMOY 9-in-1 panel to lung cancer patients

Published:2023-05 Issue: Volume:179 Page:107190
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kunimasa Kei^ORCID,Matsumoto Shingo,Kawamura Takahisa,Inoue Takako,Tamiya Motohiro,Kanzaki Ryu,Maniwa Tomohiro,Okami Jiro,Honma Keiichiro,Goto Koichi,Nishino Kazumi^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

2. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

3. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J. Natl. Compr. Canc. Netw.,2022

4. The effect of advances in lung-cancer treatment on population mortality;Howlader;N. Engl. J. Med.,2020

5. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group;Mosele;Ann. Oncol.,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panel;Respiratory Investigation;2024-09

2. Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients;Cancer Medicine;2024-09

3. Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study;Targeted Oncology;2024-07-11

4. Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer;Thoracic Cancer;2024-06-19

5. Brief Report: Tepotinib as a Treatment Option in MET Exon 14 Skipping-Positive Lung Cancers—Investigating Discordance Between ArcherMET and the Oncomine Dx Target Test;JTO Clinical and Research Reports;2024-06